Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other Working Capital Changes (2016 - 2025)

Standard Biotools (LAB) has disclosed Other Working Capital Changes for 16 consecutive years, with -$2.1 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 137.97% to -$2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Dec 2025, down 211.51% year-over-year, with the annual reading at -$1.1 million for FY2025, 211.51% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$2.1 million at Standard Biotools, down from $445000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $5.4 million in Q4 2024, with the low at -$5.3 million in Q3 2024.
  • Average Other Working Capital Changes over 5 years is $115315.8, with a median of $156000.0 recorded in 2021.
  • The sharpest move saw Other Working Capital Changes crashed 716.13% in 2023, then soared 469.25% in 2024.
  • Over 5 years, Other Working Capital Changes stood at $2.7 million in 2021, then decreased by 12.68% to $2.4 million in 2022, then plummeted by 162.02% to -$1.5 million in 2023, then skyrocketed by 469.25% to $5.4 million in 2024, then crashed by 137.97% to -$2.1 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$2.1 million, $445000.0, and $92000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.